New eye gel could make needle shots less painful
NCT ID NCT07456826
First seen Mar 19, 2026 · Last updated Apr 30, 2026 · Updated 8 times
Summary
This study compares a new numbing gel (chloroprocaine) to the usual numbing drops plus a small injection for people getting eye injections for conditions like macular degeneration or diabetic eye disease. About 236 adults will be randomly assigned to one of the two numbing methods. The goal is to see if the gel works just as well at preventing pain during the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY (DR) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tyler Retina Research Institute
Tyler, Texas, 75703, United States
Conditions
Explore the condition pages connected to this study.